Prioritisation strategy and criteria (ANSES)

The prioritisation strategy will be transparent credible and accountable and will set out the procedures by which substances will be prioritised for inclusion in HBM surveys analysis andor research under HBM4EU Decisions regarding which substances to work on will be based on a set of criteria that capture both scientific evidence aspects regulatory demands societal concerns and take into account financial and technical feasibility With regards to human exposure the criteria will take into account environmental consumer and occupational exposure pathways ANSES is LTP to INSERM and is responsible for this deliverableANSES is LTP to INSERM and is responsible for this deliverable